Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Australian Clinical Labs Ltd ( (AU:ACL) ) is now available.
Mitsubishi UFJ Financial Group, Inc. has become a substantial holder in Australian Clinical Labs Ltd, acquiring a significant voting power of 5.06% through various associates. This acquisition indicates a strategic move by Mitsubishi UFJ Financial Group to strengthen its influence within the company, potentially impacting the company’s future decisions and market positioning.
More about Australian Clinical Labs Ltd
YTD Price Performance: -14.41%
Average Trading Volume: 945,315
Technical Sentiment Signal: Buy
Current Market Cap: A$577.8M
For detailed information about ACL stock, go to TipRanks’ Stock Analysis page.